Results 81 to 90 of about 11,064 (108)

Evaluating the osteoclastogenic potential of peripheral blood mononuclear cells in children with chronic nonbacterial osteomyelitis. [PDF]

JBMR Plus
Bui JP, Curry JM, Kent JM, Hurford IM, Fullbright L, Danosky P, Sanders K, Paluvayi S, Garcia W, Ruppe AM, Cheung M, Saack A, Bao X, Luey A, Kim MH, McDaniel EE, Chiu A, Ahn S, Park JW, Thirunahari S, Wei C, Liau A, Pham TS, Van Den Bogaerde SJ, Scheck J, Muse I, Klein A, Wang X, Allenspach EJ, Cassat JE, Zhao Y.   +30 more
europepmc   +1 more source

Subcutaneous Abatacept in New Onset Type 1 Diabetes: Clinical and Immunological Effects. [PDF]

Diabetes Metab Res Rev
Jerram ST, Yang JHM, Williams E, Domingo-Vila C, Liu YF, Peakman M, Leslie RD, Tree T.   +7 more
europepmc   +1 more source

Neuroinflammation in CTLA-4 Haploinsufficiency: Case Report of a New Variant with Remarkable Response to Targeted Therapy. [PDF]

Int J Mol Sci
Baldini L, Del Vecchio L, Cerasi S, Fetta A, Moratti M, Bezzi A, Ferrari S, Di Dalmazi G, Rossi S, Toni F, Cordelli DM, Lanari M, Conti F.   +12 more
europepmc   +1 more source

FDA Approval Summary: Abatacept for the Prophylaxis of Acute GVHD. [PDF]

Clin Cancer Res
Norsworthy KJ, Rivera DR, Wynne J, Zhao J, Konicki R, Kuzucan A, Vallejo J, Leong R, Okusanya OO, Booth B, Kluetz PG, Pazdur R, de Claro RA.   +12 more
europepmc   +1 more source

Refractory Generalised Morphea in Association with Reactive Hypereosinophil Syndrome Successfully Managed with Abatacept.

Indian J Dermatol
Lluch-Galcerá JJ, Casafont-Solé I, Xicoy B, Quer A, Bielsa I.   +4 more
europepmc   +1 more source

HLA-DR risk variants in rheumatoid arthritis: what we know and still do not know. [PDF]

RMD Open
Yap CF, Viatte S.
europepmc   +1 more source

Interstitial lung disease constitutes a significant treatment burden in patients with rheumatoid arthritis. [PDF]

Front Med (Lausanne)
Aramaki T, Kojima K, Michituji T, Takatani A, Terada K, Eguchi K, Ueki Y, Iwamoto N, Kawakami A.   +8 more
europepmc   +1 more source

Risk of hepatitis B virus reactivation following treatment with abatacept: A retrospective study of international pharmacovigilance databases

EClinicalMedicine, 2022
Juanjuan Shi, Xiaoli Jia, Shuangsuo Dang   +2 more
exaly  

A review on applications of abatacept in systemic rheumatic diseases

International Immunopharmacology, 2021
Yikai Yu, Shaoxian Hu
exaly